First Point-of-Care Hepatitis C Test Authorized by FDA
U.S. Food and Drug Administration
The RNA-based test enables single-visit testing for HCV in about an hour, streamlining access to treatment
Liver Disease
FDA Approves First Treatment for NASH-Related Liver Scarring
U.S. Food and Drug Administration
The FDA granted the approval of Rezdiffra to Madrigal Pharmaceuticals
Machine Learning Model Accurately Predicts Liver Cancer Risk
University of California - Davis Health System
New algorithms developed by clinicians and data scientists could help personalize treatment
3D Printed Tissue Model Could Aid Liver Disease Research
Sanford Burnham Prebys Medical Discovery Institute
MASH is expected to surpass hepatitis C as the main cause of liver transplantation in the US
New Organ-on-Chip Model Accelerates Personalized Cancer Research
Politecnico di Milano
The 3D microchip works as a patient-specific drug-testing platform for a rare liver cancer
Mailed Outreach Nearly Doubled Liver Cancer Screening Rates
University of Pennsylvania School of Medicine
Unconditional financial incentives and text messaging orders didn’t impact the response rate
Unlocking the Power of Breath Biomarkers
Lucy Godbeer, MSc
The gut microbiome is responsible for producing many volatile chemicals found in exhaled breath
Liver Cancer Adjuvant Immunotherapy Improved Survival in Phase 3 Trial
National Cancer Centre Singapore
Some 70–90 percent of patients with hepatocellular carcinoma experience cancer recurrence after curative treatment
3 Ways to Improve Hepatitis C Diagnostics
Tyler Radke, MLS(ASCP)CM
Changes to hepatitis C testing strategies improve patient care through earlier detection and completed testing
PFAS Exposure May Suppress T-Cell Activity
Helmholtz Centre for Environmental Research (UFZ)
Study demonstrates immune-modifying effect of PFAS using multiparameter spectral flow cytometry